Skip to product information
1 of 1

Invivo Anti-Mouse IL-27 p28 Recombinant mAb

Invivo Anti-Mouse IL-27 p28 Recombinant mAb

Catalog Number: S0B7183 Application: ELISA, WB, in vivo neutralization, in vitro neutralization Reactivity: Ms Conjugation: Unconjugated Brand: Starter
Price:
Regular price $175 USD
Regular price Sale price $175 USD
Size:

For shipping services or bulk orders, you may request a quotation.
Secure checkout with
View full details

Product Details

Product Specification


Host Mouse
Antigen IL-27 p28
Synonyms Interleukin-27 subunit alpha; IL-27 subunit alpha; IL-27-A; IL27-AAlternative namep28; Il27a; Il27
Location Secreted
Accession Q8K3I6
Clone Number S-5534
Antibody Type Mouse mAb
Isotype Mouse IgG2a, κ
Isotype Control S0B0787
Application ELISA, WB, in vivo neutralization, in vitro neutralization
Reactivity Ms
Purification Protein A
Concentration 5 mg/ml
Purity >95% (Determined by SDS-PAGE)
Endotoxin <1EU/mg
Conjugation Unconjugated
Physical Appearance Liquid
Storage Buffer

PBS pH7.4, containing no preservative

Stability & Storage

2 to 8 °C for 2 weeks under sterile conditions;
-20 °C for 3 months under sterile conditions;
-80 °C for 24 months under sterile conditions.
Please avoid repeated freeze-thaw cycles.

Dilution


application dilution species
WB 1:1000 Ms

Background

IL-27 p28 (also known as IL-27A) is a unique subunit of the heterodimeric cytokine IL-27, which covalently links with another subunit, EBI3 (Epstein-Barr virus-induced gene 3), via a disulfide bond to form the biologically active IL-27 complex. Structurally, p28 belongs to the IL-6/IL-12 family of α-helical four-helix bundle cytokines and is primarily produced by activated antigen-presenting cells (such as dendritic cells and macrophages) following stimulation with Toll-like receptor agonists or interferons. The function of p28 exhibits significant cell type-dependent effects: in naive T cells, IL-27 composed of p28 primarily activates STAT1 and STAT3 signaling pathways through the gp130 and WSX-1 receptor complex, promoting Th1-type immune responses and enhancing the cytotoxic function of CD8⁺ T cells, thereby playing a critical role in anti-infective immunity. However, in regulatory T cells (Tregs), p28 can signal in a non-canonical manner independently of EBI3, and IL-27 itself also exhibits immunosuppressive properties, capable of limiting excessive inflammation and inducing IL-10 production. Consequently, it plays a dual pro-inflammatory and anti-inflammatory role in autoimmune diseases and antitumor immunity, positioning it as a double-edged sword target of great interest in the field of immunotherapy.

Picture

Western Blot

WB result of Invivo Anti-Mouse IL-27 p28 Recombinant mAb
Primary antibody: Invivo Anti-Mouse IL-27 p28 Recombinant mAb at 1/1000 dilution
Lane 1: IL-27 p28 protein, mouse lysate 10 ng
Secondary antibody: Goat Anti-Mouse IgG (H+L), HRP conjugated at 1/10000 dilution
Predicted MW: 50 kDa
Observed MW: 60 kDa